» Articles » PMID: 7517713

Stem Cell Factor Enhances the Survival but Not the Self-renewal of Murine Hematopoietic Long-term Repopulating Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1994 Jul 15
PMID 7517713
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of stem cell factor (SCF) have been tested on a murine bone marrow subpopulation (RH123lo, Lin-, Ly6A/E+) that is highly enriched for long-term hematopoietic repopulating cells. SCF maintained cells from this population with long-term repopulating ability for up to 10 days in vitro. However, compared with freshly isolated cells, the level of engraftment in vivo by the cultured cells declined during the in vitro culture period, suggesting that SCF alone was unable to stimulate the self-renewal of long-term repopulating cells. By direct visualization of cultures, only small numbers of cells survived and rarely underwent cell division. However, SCF did directly stimulate proliferation of a population (Rh123med/hi,Lin-,Ly6A/E+) enriched for short-term repopulating cells. These data suggest that stem cell differentiation is associated with the development of mitogenic activity by SCF at least in some progenitor cell populations.

Citing Articles

Transmembrane stem factor nanodiscs enhanced revascularization in a hind limb ischemia model in diabetic, hyperlipidemic rabbits.

Takematsu E, Massidda M, Howe G, Goldman J, Felli P, Mei L Sci Rep. 2024; 14(1):2352.

PMID: 38287067 PMC: 10825164. DOI: 10.1038/s41598-024-52888-6.


ID2 and HIF-1α collaborate to protect quiescent hematopoietic stem cells from activation, differentiation, and exhaustion.

Jakubison B, Sarkar T, Gudmundsson K, Singh S, Sun L, Morris H J Clin Invest. 2022; 132(13).

PMID: 35775482 PMC: 9246389. DOI: 10.1172/JCI152599.


Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis.

Gonzalez-Lopez O, Munoz-Gonzalez J, Orfao A, Alvarez-Twose I, Garcia-Montero A Cancers (Basel). 2022; 14(10).

PMID: 35626091 PMC: 9139197. DOI: 10.3390/cancers14102487.


Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation.

Takematsu E, Massidda M, Auster J, Chen P, Im B, Srinath S Nat Commun. 2022; 13(1):2497.

PMID: 35523773 PMC: 9076913. DOI: 10.1038/s41467-022-30103-2.


Hematopoietic Stem Cells and Regeneration.

Biermann M, Reya T Cold Spring Harb Perspect Biol. 2021; 14(8).

PMID: 34750175 PMC: 9341464. DOI: 10.1101/cshperspect.a040774.